Clinical Trials on Hypertension, Dyslipidemia

Total 13389 results

Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348 (CKD-348)

Hypertension | Dyslipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers

Hypertension | Dyslipidemias

Korea, Republic of
Sanofi
Bristol-Myers Squibb

Completed

Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions

Hypertension | Dyslipidemia

Hungary
Daewoong Pharmaceutical Co. LTD.

Recruiting

Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia

Hypertension | Dyslipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet

Hypertension | Dyslipidemias

Korea, Republic of
IlDong Pharmaceutical Co Ltd

Unknown

To Evaluate the Pharmacokinetic/Pharmacodynamic Interactions and Safety Between ID1801 and ID1803 in Healthy Male Adults

Hypertension | Dyslipidemias
Texas Woman's University

Completed

Effect of Pumpkin Seed Oil or Pumpkin Seeds on Blood Pressure and Menopausal Symptoms in Postmenopausal Women

Hypertension | Dyslipidemia

United States
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)

Hypertension | Dyslipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers

Hypertension | Dyslipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults

Hypertension | Dyslipidemias

Korea, Republic of
IlDong Pharmaceutical Co Ltd

Unknown

Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and Efficacy

Hypertension | Dyslipidemias
Purdue University

Completed

The Effects of Pork vs. Chicken/Fish in a DASH Diet on Blood Pressure Regulation in Middle Aged and Older Adults (S31)

Hypertension | Dyslipidemias

United States
Boryung Pharmaceutical Co., Ltd

Completed

Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia (FIRST)

Dyslipidemia | Essential Hypertension

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Unknown

Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia

Hypertension | Dyslipidemias

Korea, Republic of
Servier Russia

Completed

Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET) (TARGET)

Arterial Hypertension | HTN

Russian Federation
IlDong Pharmaceutical Co Ltd

Recruiting

To Evaluate the Pharmacokinetics and the Safety of ID14009 Compared to Coadministration of ID1805 With ID1803 in Healthy Adult Volunteers

Hypertension | Dyslipidemias

Korea, Republic of
Public Health Foundation of India
National Heart, Lung, and Blood Institute (NHLBI); All India Institute of Medical... and other collaborators

Unknown

A Multi-site, Individually Randomized, Controlled Translation Trial of Integrated and Comprehensive Care Strategies to Reduce Cardiovascular Disease (CVD) Risk Among 1,120 Type 2 Diabetes Mellitus(T2DM) Patients in South Asia (CARRS)

Hypertension | Type 2 Diabetes Mellitus | Dyslipidaemia

India, Pakistan
University Health Network, Toronto
Canadian Institutes of Health Research (CIHR)

Completed

Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol

Insulin Resistance | Dyslipidaemia

Canada
GlaxoSmithKline

Completed

A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers

Healthy Subjects | Dyslipidaemias

United States
Daewoong Pharmaceutical Co. LTD.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab

Hypertension | Dyslipidemias

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Enrolling by invitation

Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab

Hypertension | Dyslipidemia

Korea, Republic of
Yuhan Corporation

Completed

Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension

Hypertension | Dyslipidemia

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia (JEWEL I)

Hypertension | Dyslipidemia

Canada, United Kingdom
EMS

Withdrawn

Efficacy of Fixed-doses of Antihypertensive and Statin Drugs

Hypertension | Dyslipidemia
Yonsei University

Completed

Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

Hypertension | Dyslipidemias

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

Clinical Study for Patients With Hypertension Associated With Dyslipidemia

Hypertension | Dyslipidemia

Korea, Republic of
Lawson Health Research Institute
University of Western Ontario, Canada; The Physicians' Services Incorporated...

Completed

Risk Assessment and Treat Compliance in Hypertension Education Trial (RATCHET)

Hypertension | Dyslipidemia

Canada
JW Pharmaceutical

Completed

To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension

Hypertension | Dyslipidemia

Korea, Republic of
Yuhan Corporation

Completed

Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia (CORONA)

Hypertension | Dyslipidemias

Korea, Republic of
EMS

Withdrawn

Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.

Hypertension | Dyslipidemia
Hyo-Soo Kim

Unknown

The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin

Hypertension | Dyslipidemias
Chong Kun Dang Pharmaceutical

Completed

Pharmacokinetics and Safety Profile of CKD-333

Hypertension | Dyslipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects

Hypertension | Dyslipidemias

Korea, Republic of
Daewon Pharmaceutical Co., Ltd.

Completed

Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia

Hypertension | Dyslipidemia

Korea, Republic of
Novartis

Completed

Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction

Hypertension | Dyslipidemia

Russian Federation
AstraZeneca

Completed

Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension ) (RUSH)

Hypertension | Dyslipidemia

Korea, Republic of
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Terminated

Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia

Hypertension | Dyslipidemias

Georgia, Russian Federation, Ukraine
Hanmi Pharmaceutical Company Limited

Completed

An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet

Hypertension | Dyslipidemia

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk (TOGETHER)

Hypertension | Dyslipidemia

United States
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia

Hypertension | Dyslipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects

Hypertension | Dyslipidemias

Korea, Republic of
JW Pharmaceutical

Completed

Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia (COCTAIL)

Hypertension | Dyslipidemia

Korea, Republic of
Boehringer Ingelheim

Completed

Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia

Hypertension | Dyslipidemias

Taiwan, Netherlands, Czech Republic, France, Germany, Hong Kong, Korea, Republic of, Russian Federation, Slovakia, South Africa, Sweden, Ukraine
Universidade Federal do Rio de Janeiro
Conselho Nacional de Desenvolvimento Científico e Tecnológico; Rio de Janeiro...

Unknown

Supplementation With Flaxseed Oil in the State of Rio de Janeiro

Hypertension | Dyslipidemia

Brazil
Azienda Ospedaliera Universitaria Integrata Verona
Societa Italiana dell'Ipertensione Arteriosa

Not yet recruiting

Study of Adherence to Antihypertensive Drugs and Statins by Hair Analysis (INNOVA)

Dyslipidemias | Treatment Adherence | Arterial Hypertension | Antihypertensive Drugs | Statins

Italy
GlaxoSmithKline

Completed

An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation

Obesity | Hypercholesterolemia | Dyslipidaemias

United States
GlaxoSmithKline

Terminated

Effect Of GW501516X On How The Heart Obtains And Uses Energy

Heart Failure | Dyslipidaemias

United States
Charles University, Czech Republic
Brno University Hospital; University Hospital Olomouc; University Hospital Pilsen and other collaborators

Withdrawn

Fixed Combination for Lipid and Blood Pressure Control (FILIP)

Dyslipidemias | Lipid Metabolism Disorders | Blood Pressure | Arterial Hypertension

Czechia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. (JEWEL II)

Hypertension | Hyperlipidemia

Greece, Austria, Finland, Italy, Hungary, Belgium, Spain, Ireland, Portugal, Slovenia, Switzerland
University of Arkansas

Terminated

Is a Smartphone Application Effective as an Oral Medication Adherence Aid

Hypertension | Diabetes | Dyslipidemia

United States

Clinical Trials on Hypertension, Dyslipidemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations